MedTrace Logo

Think Life, an Online Self-help Intervention for Coping With Suicidal Ideation

NCT03209544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 724

Last updated 2017-07-06

No results posted yet for this study

Summary

The objective of the Think Life study is to test the effect of an online, unguided self-help intervention, i.e. Think Life. The primary hypothesis is that Think Life will reduce suicidal ideation. The secondary hypothesis is that Think Life will lead to improvements in depressive symptoms, hopelessness, rumination, and anxiety. Positive changes are expected after completing Think Life and at follow-up, twelve weeks after baseline.

Conditions

Interventions

BEHAVIORAL

Online self-help intervention

The intervention was originally developed by van Spijker, van Straten, and Kerkhof (2010). For this study, it was adapted to the Flemish context and called Think Life. Think Life is mainly based Cognitive Behaviour Therapy (CBT). Additionally, it encompasses elements from Dialectical Behaviour Therapy (DBT), Problem Solving Therapy (PST), and Mindfulness Based Cognitive Therapy (MBCT). It encompasses six modules and every module starts with a psycho-educational section followed by a weekly assignment, core exercises and optional exercises. The participant weekly receives access to a new module. A more detailed description of the intervention is described elsewhere (Kerkhof, van Spijker, \& Mokkenstorm, 2013; van Spijker et al., 2010; van Spijker, van Straten, et al., 2014).

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER

  • University Ghent

    lead OTHER

Principal Investigators

  • Kees van Heeringen, MD, PhD · Ghent Univeristy - Flemish Centre for Expertise in Suicide Prevention

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-23
Primary Completion
2015-12-07
Completion
2016-02-24

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209544 on ClinicalTrials.gov